Cross-source evidence timeline
Lixisenatide research timeline
Follow 64 selected, directly cited source records from December 15, 2015 through July 30, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.
Source year
2026
Literature metadata
PubMed record PMID 39604042↗
PeptideScanner retained PubMed bibliographic metadata for PMID 39604042 at 2026-07-30T16:31:16.748Z. PubMed recorded a metadata revision date of 2026-07-30 and an Entrez history date of 2024-11-27. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 38870730↗
PeptideScanner retained PubMed bibliographic metadata for PMID 38870730 at 2026-08-10T18:13:32.367Z. PubMed recorded a metadata revision date of 2026-07-02 and an Entrez history date of 2024-06-13. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 38685598↗
PeptideScanner retained PubMed bibliographic metadata for PMID 38685598 at 2026-07-30T16:14:06.932Z. PubMed recorded a metadata revision date of 2026-06-18 and an Entrez history date of 2024-04-30. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Literature metadata
PubMed record PMID 38877681↗
PeptideScanner retained PubMed bibliographic metadata for PMID 38877681 at 2026-07-30T16:20:38.897Z. PubMed recorded a metadata revision date of 2026-05-31 and an Entrez history date of 2024-06-15. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 39407425↗
PeptideScanner retained PubMed bibliographic metadata for PMID 39407425 at 2026-07-30T16:20:39.038Z. PubMed recorded a metadata revision date of 2026-05-31 and an Entrez history date of 2024-10-16. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 22564709↗
PeptideScanner retained PubMed bibliographic metadata for PMID 22564709 at 2026-07-30T16:20:34.419Z. PubMed recorded a metadata revision date of 2026-05-18 and an Entrez history date of 2012-05-09. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 39157869↗
PeptideScanner retained PubMed bibliographic metadata for PMID 39157869 at 2026-07-30T16:23:36.341Z. PubMed recorded a metadata revision date of 2026-03-23 and an Entrez history date of 2024-08-19. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Regulatory
Lixisenatide DailyMed SPL version 25↗
DailyMed lists Structured Product Labeling version 25 for the reviewed Lixisenatide label family with a published date of 2026-03-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Literature metadata
PubMed record PMID 41623754↗
PeptideScanner retained PubMed bibliographic metadata for PMID 41623754 at 2026-07-30T16:25:14.225Z. PubMed recorded a metadata revision date of 2026-02-04 and an Entrez history date of 2026-02-02. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 25012990↗
PeptideScanner retained PubMed bibliographic metadata for PMID 25012990 at 2026-07-30T16:30:52.644Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-07-12. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 25055456↗
PeptideScanner retained PubMed bibliographic metadata for PMID 25055456 at 2026-07-30T16:30:52.649Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-07-25. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 25115916↗
PeptideScanner retained PubMed bibliographic metadata for PMID 25115916 at 2026-07-30T16:30:52.653Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-08-14. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 25130920↗
PeptideScanner retained PubMed bibliographic metadata for PMID 25130920 at 2026-07-30T16:30:52.654Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2014-08-19. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 26039935↗
PeptideScanner retained PubMed bibliographic metadata for PMID 26039935 at 2026-07-30T16:30:54.214Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2015-06-04. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 26423184↗
PeptideScanner retained PubMed bibliographic metadata for PMID 26423184 at 2026-07-30T16:30:54.263Z. PubMed recorded a metadata revision date of 2026-01-28 and an Entrez history date of 2015-10-02. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
Insulin degludec, Lixisenatide, and Patiromer sorbitex calcium.↗
PubMed lists PMID 27836130 in Journal of the American Pharmacists Association : JAPhA as Journal Article, with publication-date metadata of 2016 Nov-Dec (source-text precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: 2016 Nov-Dec · source-text precisionAdded to PeptideScanner August 13, 2026Literature metadata
Lixisenatide for type 2 diabetes.↗
PubMed lists PMID 28118649 in The Medical letter on drugs and therapeutics as Journal Article, Review, with publication-date metadata of 2017-01-30 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 30, 2017 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Lixisenatide (Adlyxin) for Type 2 Diabetes Mellitus.↗
PubMed lists PMID 28925668 in American family physician as Journal Article, with publication-date metadata of 2017-08-15 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: August 15, 2017 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Glycaemic target attainment in people with Type 2 diabetes treated with insulin glargine/lixisenatide fixed-ratio combination: a post hoc analysis of the LixiLan-O and LixiLan-L trials.↗
PubMed lists PMID 31365765 in Diabetic medicine : a journal of the British Diabetic Association as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-11-26 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: November 26, 2019 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Lixisenatide versus insulin glulisine on top of insulin glargine in patients with type 2 diabetes mellitus: a cost-per-responder analysis in China.↗
PubMed lists PMID 31469303 in Current medical research and opinion as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-09-11 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 11, 2019 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Mexican population sub-analysis of the lixilan clinical program with the fixed ratio combination of insulin glargine and lixisenatide (iGlarLixi).↗
PubMed lists PMID 32561160 in Journal of diabetes and its complications as Clinical Trial, Phase II, Clinical Trial, Phase III, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2019-05-31 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: May 31, 2019 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) compared with premix or addition of meal-time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesi…↗
PubMed lists PMID 32700442 in Diabetes, obesity & metabolism as Journal Article, Research Support, Non-U.S. Gov't, Systematic Review, Network Meta-Analysis, with publication-date metadata of 2020-09-03 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 3, 2020 · day precisionAdded to PeptideScanner August 13, 2026
Source year
2025
Clinical trials
ClinicalTrials.gov record NCT03439943↗
PeptideScanner retained ClinicalTrials.gov record NCT03439943 at 2026-07-30T18:19:48.216Z. Its registry update date was 2025-11-28, and PeptideScanner's reviewed identity mapping was lixisenatide.↗
Added to PeptideScanner August 8, 2026Regulatory
Lixisenatide DailyMed SPL version 23↗
DailyMed lists Structured Product Labeling version 23 for the reviewed Lixisenatide label family with a published date of 2025-08-01. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Lixisenatide DailyMed SPL version 22↗
DailyMed lists Structured Product Labeling version 22 for the reviewed Lixisenatide label family with a published date of 2025-06-13. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Literature metadata
Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.↗
PubMed lists PMID 26981945 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 17, 2016 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.↗
PubMed lists PMID 26981946 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 17, 2016 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome.↗
PubMed lists PMID 26981947 in The New England journal of medicine as Letter, Comment, with publication-date metadata of 2016-03-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: March 17, 2016 · day precisionAdded to PeptideScanner August 13, 2026
Source year
2024
Clinical trials
ClinicalTrials.gov record NCT02049034↗
PeptideScanner retained ClinicalTrials.gov record NCT02049034 at 2026-07-30T18:37:14.684Z. Its registry update date was 2024-12-16, and PeptideScanner's reviewed identity mapping was lixisenatide.↗
Added to PeptideScanner August 14, 2026Regulatory
Lixisenatide DailyMed SPL version 19↗
DailyMed lists Structured Product Labeling version 19 for the reviewed Lixisenatide label family with a published date of 2024-11-14. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Literature metadata
Poly(l-threonine-co-l-threonine Succinate) Thermogels for Sustained Release of Lixisenatide.↗
PubMed lists PMID 38949062 in Biomacromolecules as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2024-07-01 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: July 1, 2024 · day precisionAdded to PeptideScanner August 13, 2026Literature metadata
Lixisenatide.↗
PubMed lists PMID 28179743 in Hospital pharmacy as Journal Article, with publication-date metadata of 2017-01 (month precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 2017 · month precisionAdded to PeptideScanner August 13, 2026
Source year
2023
Regulatory
Lixisenatide DailyMed SPL version 18↗
DailyMed lists Structured Product Labeling version 18 for the reviewed Lixisenatide label family with a published date of 2023-10-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Literature metadata
Comprehensive Evaluation of Combination Therapy with Basal Insulin and Either Lixisenatide or Vildagliptin in Japanese Patients with Type 2 Diabetes: A Randomized, Open-Label, Parallel-Group, Multice…↗
PubMed lists PMID 30206903 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2018-09-11 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: September 11, 2018 · day precisionAdded to PeptideScanner August 13, 2026
Source year
2022
Regulatory
Lixisenatide DailyMed SPL version 17↗
DailyMed lists Structured Product Labeling version 17 for the reviewed Lixisenatide label family with a published date of 2022-06-20. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026
Source year
2021
Regulatory
Lixisenatide DailyMed SPL version 16↗
DailyMed lists Structured Product Labeling version 16 for the reviewed Lixisenatide label family with a published date of 2021-08-09. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Literature metadata
Austrian Experience with Lixisenatide Under Real-Life Conditions: A Prospective Observational Study.↗
PubMed lists PMID 30656523 in Diabetes therapy : research, treatment and education of diabetes and related disorders as Journal Article, with publication-date metadata of 2019-01-17 (day precision). PeptideScanner associated the retained record with the identity slug lixisenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Attributed publication date: January 17, 2019 · day precisionAdded to PeptideScanner August 13, 2026
Source year
2020
Regulatory
Lixisenatide DailyMed SPL version 15↗
DailyMed lists Structured Product Labeling version 15 for the reviewed Lixisenatide label family with a published date of 2020-12-04. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Lixisenatide DailyMed SPL version 14↗
DailyMed lists Structured Product Labeling version 14 for the reviewed Lixisenatide label family with a published date of 2020-07-16. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Clinical trials
ClinicalTrials.gov record NCT02640118↗
PeptideScanner retained ClinicalTrials.gov record NCT02640118 at 2026-07-30T20:27:50.520Z. Its registry update date was 2020-05-07, and PeptideScanner's reviewed identity mapping was lixisenatide.↗
Added to PeptideScanner August 8, 2026Regulatory
Lixisenatide DailyMed SPL version 13↗
DailyMed lists Structured Product Labeling version 13 for the reviewed Lixisenatide label family with a published date of 2020-03-31. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Literature metadata
PubMed record PMID 31873867↗
PeptideScanner retained PubMed bibliographic metadata for PMID 31873867 at 2026-07-30T20:33:08.013Z. PubMed recorded a metadata revision date of 2020-02-26 and an Entrez history date of 2019-12-25. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Regulatory
Lixisenatide DailyMed SPL version 12↗
DailyMed lists Structured Product Labeling version 12 for the reviewed Lixisenatide label family with a published date of 2020-01-24. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026
Source year
2019
Regulatory
Lixisenatide DailyMed SPL version 11↗
DailyMed lists Structured Product Labeling version 11 for the reviewed Lixisenatide label family with a published date of 2019-12-19. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Lixisenatide DailyMed SPL version 10↗
DailyMed lists Structured Product Labeling version 10 for the reviewed Lixisenatide label family with a published date of 2019-12-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Lixisenatide DailyMed SPL version 9↗
DailyMed lists Structured Product Labeling version 9 for the reviewed Lixisenatide label family with a published date of 2019-12-10. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Lixisenatide DailyMed SPL version 8↗
DailyMed lists Structured Product Labeling version 8 for the reviewed Lixisenatide label family with a published date of 2019-11-26. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Literature metadata
PubMed record PMID 30736157↗
PeptideScanner retained PubMed bibliographic metadata for PMID 30736157 at 2026-07-30T20:44:20.586Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2019-02-10. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 30736158↗
PeptideScanner retained PubMed bibliographic metadata for PMID 30736158 at 2026-07-30T20:44:20.587Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2019-02-10. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 12, 2026Literature metadata
PubMed record PMID 28420696↗
PeptideScanner retained PubMed bibliographic metadata for PMID 28420696 at 2026-07-30T20:44:20.465Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2017-04-20. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 11, 2026Literature metadata
PubMed record PMID 28428368↗
PeptideScanner retained PubMed bibliographic metadata for PMID 28428368 at 2026-07-30T20:44:20.465Z. PubMed recorded a metadata revision date of 2019-11-20 and an Entrez history date of 2017-04-22. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Regulatory
Lixisenatide DailyMed SPL version 7↗
DailyMed lists Structured Product Labeling version 7 for the reviewed Lixisenatide label family with a published date of 2019-03-05. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026
Source year
2018
Regulatory
Federal Register notice 2018-27805↗
The Federal Register published notice 2018-27805, attributed to FDA and its parent HHS department, on 2018-12-26. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; ADLYXIN,” and PeptideScanner's exact reviewed identity mapping connects the document to Lixisenatide.↗
Added to PeptideScanner August 21, 2026Regulatory
Federal Register notice 2018-07256↗
The Federal Register published notice 2018-07256, attributed to FDA and its parent HHS department, on 2018-04-10. Its official title is “Notice of Approval of Products Under Voucher: Rare Pediatric Disease Priority Review Vouchers,” and PeptideScanner's exact reviewed identity mapping connects the document to Lixisenatide.↗
Added to PeptideScanner August 21, 2026Regulatory
Lixisenatide DailyMed SPL version 6↗
DailyMed lists Structured Product Labeling version 6 for the reviewed Lixisenatide label family with a published date of 2018-03-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026
Source year
2017
Clinical trials
ClinicalTrials.gov record NCT02745470↗
PeptideScanner retained ClinicalTrials.gov record NCT02745470 at 2026-07-30T21:22:00.254Z. Its registry update date was 2017-11-29, and PeptideScanner's reviewed identity mapping was lixisenatide.↗
Added to PeptideScanner September 9, 2026Regulatory
Lixisenatide DailyMed SPL version 5↗
DailyMed lists Structured Product Labeling version 5 for the reviewed Lixisenatide label family with a published date of 2017-10-12. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Lixisenatide DailyMed SPL version 4↗
DailyMed lists Structured Product Labeling version 4 for the reviewed Lixisenatide label family with a published date of 2017-09-07. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026
Source year
2016
Regulatory
Lixisenatide DailyMed SPL version 1↗
DailyMed lists Structured Product Labeling version 1 for the reviewed Lixisenatide label family with a published date of 2016-11-22. PeptideScanner retained the exact versioned ZIP byte count and SHA-256 receipt without republishing its contents.↗
Added to PeptideScanner August 22, 2026Regulatory
Drugs@FDA application BLA208471↗
The official Drugs@FDA dataset lists original submission 1 for BLA 208471 with status AP dated 2016-07-27, and names lixisenatide among the application record's active ingredients.↗
Added to PeptideScanner August 14, 2026Literature metadata
PubMed record PMID 27200667↗
PeptideScanner retained PubMed bibliographic metadata for PMID 27200667 at 2026-07-30T21:38:23.145Z. PubMed recorded a metadata revision date of 2016-05-21 and an Entrez history date of 2016-05-21. PeptideScanner associated this retained record with the identity slug lixisenatide. These dates describe PubMed metadata history, not the article's original publication date.↗
Added to PeptideScanner August 10, 2026Clinical trials
ClinicalTrials.gov record NCT02276196↗
PeptideScanner retained ClinicalTrials.gov record NCT02276196 at 2026-07-30T21:37:20.821Z. Its registry update date was 2016-04-29, and PeptideScanner's reviewed identity mapping was lixisenatide.↗
Added to PeptideScanner August 9, 2026Regulatory
Federal Register notice 2016-05931↗
The Federal Register published notice 2016-05931, attributed to FDA and its parent HHS department, on 2016-03-16. Its official title is “Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Lixisenatide.↗
Added to PeptideScanner August 21, 2026
Source year
2015
Clinical trials
ClinicalTrials.gov record NCT02020629↗
PeptideScanner retained ClinicalTrials.gov record NCT02020629 at 2026-07-30T21:39:57.678Z. Its registry update date was 2015-12-15, and PeptideScanner's reviewed identity mapping was lixisenatide.↗
Added to PeptideScanner August 9, 2026